AAAAAA

   
Results: 1-10 |
Results: 10
Evolving treatment options of myelodysplastic syndromes
Authors: Verbeek, W Ganser, A
Citation: W. Verbeek et A. Ganser, Evolving treatment options of myelodysplastic syndromes, ANN HEMATOL, 80(9), 2001, pp. 499-509
C/EBP epsilon -/- mice: increased rate of myeloid proliferation and apoptosis
Authors: Verbeek, W Wachter, M Lekstrom-Himes, J Koeffler, HP
Citation: W. Verbeek et al., C/EBP epsilon -/- mice: increased rate of myeloid proliferation and apoptosis, LEUKEMIA, 15(1), 2001, pp. 103-111
DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein epsilon (C/EBR epsilon) gene
Authors: Kubota, T Hirama, T Verbeek, W Kawano, S Chih, DY Chumakov, AM Taguchi, H Koeffler, HP
Citation: T. Kubota et al., DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein epsilon (C/EBR epsilon) gene, LEUK RES, 25(11), 2001, pp. 981-995
Measurement of thrombopoietic levels: clinical and biological relationships
Authors: Verbeek, W Faulhaber, M Griesinger, F Brittinger, G
Citation: W. Verbeek et al., Measurement of thrombopoietic levels: clinical and biological relationships, CURR OPIN H, 7(3), 2000, pp. 143-149
Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids
Authors: Asou, H Verbeek, W Williamson, E Elstner, E Kubota, T Kamada, N Koeffler, HP
Citation: H. Asou et al., Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids, INT J ONCOL, 15(5), 1999, pp. 1027-1031
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes
Authors: Verbeek, W Wormann, B Koch, P Aul, C Hinrichs, HF Balleisen, L Rowe, JM Bennett, J Haase, D Fonatsch, C Heinecke, A Buchner, T Hiddemann, W
Citation: W. Verbeek et al., Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes, J CANC RES, 125(6), 1999, pp. 369-374
Cloning of the cyclin A1 genomic structure and characterization of the promoter region - GC boxes are essential for cell cycle-regulated transcription of the cyclin A1 gene
Authors: Muller, C Yang, R Beck-Von-Peccoz, L Idos, G Verbeek, W Koeffler, HP
Citation: C. Muller et al., Cloning of the cyclin A1 genomic structure and characterization of the promoter region - GC boxes are essential for cell cycle-regulated transcription of the cyclin A1 gene, J BIOL CHEM, 274(16), 1999, pp. 11220-11228
Myeloid transcription factor C/EBP epsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils
Authors: Verbeek, W Lekstrom-Himes, J Park, DJ Dang, PMC Vuong, PT Kawano, S Babior, BM Xanthopoulos, K Koeffler, HP
Citation: W. Verbeek et al., Myeloid transcription factor C/EBP epsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils, BLOOD, 94(9), 1999, pp. 3141-3150
c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression
Authors: Muller, C Yang, R Idos, G Tidow, N Diederichs, S Koch, OM Verbeek, W Bender, TP Koeffler, HP
Citation: C. Muller et al., c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression, BLOOD, 94(12), 1999, pp. 4255-4262
C/EBP epsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters
Authors: Verbeek, W Gombart, AF Chumakov, AM Muller, C Friedman, AD Koeffler, HP
Citation: W. Verbeek et al., C/EBP epsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters, BLOOD, 93(10), 1999, pp. 3327-3337
Risultati: 1-10 |